Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ISRCTN82301860) titled 'Evaluating tools to communicate scleroderma research results to patients - SPIN-CLEAR Trial Series Sub-study #3' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Active
Assignment: Parallel
Purpose: Quality of life
Primary Sponsor: Jewish General Hospital
Condition:
Comparison of research dissemination tools to people living with systemic sclerosis (SSc
scleroderma)
Skin and Connective Tissue Diseases
Intervention:
The investigators will use the multinational SPIN Cohort to conduct a series of RCTs to compare tools among p...